{"url_path":"/sec/uncy/8-k/2026-06-05/item-1-01","section_key":"item-1-01","section_title":"Item 1.01 Entry into a Material Definitive","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-05","source_url":"https://www.sec.gov/Archives/edgar/data/1766140/0001213900-26-065828-index.html","accession_number":"0001213900-26-065828","cik":"0001766140","ticker":"UNCY","issuer_name":"Unicycive Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1766140/0001213900-26-065828-index.html","primary_entity_key":"0001766140","primary_entity_name":"Unicycive Therapeutics, Inc."},"word_count":306,"has_tables":true,"body_markdown":"**Item 1.01. Entry into a Material Definitive\nAgreement.**\n\n \n\nAs previously\nreported, Unicycive Therapeutics, Inc. (the “Company”) entered into a Sales Agreement, dated November 13, 2024, with\nGuggenheim Securities, LLC, as sales agent (the “Agent”) as amended by Amendment No. 1 to Sales Agreement dated November\n14, 2025, between the Company and the Agent (as amended, the “Sales Agreement”), to sell shares of its common stock, par\nvalue $0.001 per share (the “Common Stock”), having an aggregate offering price of up to $100,000,000 (the\n“Shares”) from time to time, through an “at the market offering” (the “ATM Offering”) as defined\nin Rule 415 under the Securities Act of 1933, as amended.\n\n \n\nOn June 5, 2026, the\nCompany entered into Amendment No. 2 to the Sales Agreement with the Agent (the “Amendment”) to increase the number of Shares\nthat may be sold in the ATM Offering to $150,000,000. In connection with entering into the Amendment, the Company filed a Shelf Registration\nStatement on Form S-3, which includes a sales agreement prospectus (the “Registration Statement”), with the Securities and\nExchange Commission on June 5, 2026, to sell shares of its Common Stock having an aggregate offering price of $50,000,000 in the ATM Offering.\n\n \n\nThe\nforegoing description of the Amendment does not purport to be complete and is qualified in its entirety by reference to the full text\nof Amendment. A copy of the Amendment is filed as Exhibit 1.3 to the Registration Statement.\n\n \n\nThis Current Report on\nForm 8-K shall not constitute an offer to sell or the solicitation of any offer to buy the Shares or any securities, nor shall there be\nany offer, solicitation or sale of the Shares or any securities in any state in which such offer, solicitation or sale would be unlawful\nprior to registration or qualification under the securities laws of such state."}